Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000014668
JPRN-UMIN000014668CompletedPhase 2

A Randomized Controlled Trial compares the efficacy of Moviprep vs Muben on the bowel preparation of the patients who undergo colorectal endoscopic submucosal dissection - MOVI STUDY

ational Cancer Center Hospital0 sites100 target enrollmentStarted: August 15, 2014Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
100
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 75years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1. Patients having risk of perforation, obstruction and suspicious of ileum. 2. Toxic megacolon 3. Allergy for Moviprep and Muben 4. Dehydration 5. Mental disease 6. Without written informed consent 7. Angina pectoris and/or past history of myocardial infarction within 6 months. 8. Active inflammatory bowel diseases 9. Past history of convulsive attack 10. Serum creatinine level ≥1.3 mg/dL 11. Others (depends on the chief physician)

Investigators

Similar Trials

Not yet recruiting
Not Applicable
Comparison of efficacy of two insulin regimens in Patients of Acute Stroke with hyperglycemia
CTRI/2019/03/017919Smruti Babtiwale
Active, not recruiting
Not Applicable
Comparison of two components in phenol peelsSkin alterations due to chronic exposure to non-ionizing radiation unspecified/photo-agingpeeling.E02.218.170G13.750.804
RBR-9c2my6Hospital Heliópolis
Not yet recruiting
Not Applicable
A study to compare the efficacy of topical Ayurvedic oil preparation against placebo in symptomatic knee osteoarthritisKnee Osteoarthritis
SLCTR/2017/039niversity Grants Commission, Sri Lanka
Completed
Phase 3
Randomized Controlled Trial Comparing Efficacy of Sorafenib versus Sorafenib In combination with Low dose cisplatin /fluorouracil hepatic arterial InfUSion chemotherapy in Patients with Advanced Hepatocellular Carcinoma(SILIUS Phase III)HCC
JPRN-UMIN000004315SILIUS Trial Group,Japan Ministry of Health, Labour and Welfare190
Recruiting
Not Applicable
Anti-fibrotic agent in Endonasal Lacrimal Sac Surgery.
CTRI/2014/09/004989Hyderabad Eye Research Foundation440